Pune Pharmacist Under Probe for Supplying Expired Actrapid Insulin, Wrong Tablets to Patient
- byDoctor News Daily Team
- 01 November, 2025
- 0 Comments
- 0 Mins
Pune:The Pune Municipal Corporation (PMC) has launched an inquiry against a pharmacist at Late Nathuram Shankar Marathe Hospital, Kothrud, after a patient alleged that he was supplied an expired vial of Actrapid FlexPen insulin and given magnesium tablets instead of the prescribed vitamin D3 supplement. As per a recent media report in the Hindustan Times, the incident, which occurred on October 18, 2025, involved patient Prakash Shelar, an organ transplant recipient, and pharmacist Devdhar Valvi, who was on duty at the hospital’s dispensary. Officials stated that the expired insulin vial was discovered just in time by the patient before use, preventing a possible medical emergency. Following the complaint, PMC’s Health Department initiated a formal investigation into the matter. Health chief Dr Nina Borade confirmed that the pharmacist had accepted responsibility for the error. Pending inquiry, he has been transferred to Dr Homi Baba Hospital and Maternity Home in Shivajinagar, and his annual increment has been withheld until further notice. Preliminary findings have revealed that all medicines supplied to civic hospitals are procured through the Central Medical Stores (CMS) located in Gadikhana. However, the batch number of the expired insulin vial was not listed among medicines distributed by CMS during the past year. Officials also noted that the manufacturer had discontinued production of that batch two months earlier, raising concerns about how it reached the hospital’s pharmacy. The PMC has instructed its inquiry team to expedite the investigation and submit a detailed report. Senior officials warned that strict disciplinary action, including suspension or termination, would be taken if evidence confirms negligence or malpractice. TheHindustan Timesreports that the civic body is also reviewing its drug procurement and supply chain protocols to identify gaps in traceability and strengthen safety checks, ensuring that expired or unauthorized batches do not enter hospital stock in the future.
Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at
admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our
Terms of Use,
Privacy Policy, and
Advertisement Policy.
For further details, please review our
Full Disclaimer.
Recent News
Pathologist's signature on medical reports not mus...
- 02 November, 2025
UP Eyes Japanese Investment: 125 Pharma Giants Inv...
- 02 November, 2025
Delhi Govt to recruit 1,593 senior resident doctor...
- 02 November, 2025
Former Drug Inspector's Office Clerk Jailed for Ta...
- 02 November, 2025
Daily Newsletter
Get all the top stories from Blogs to keep track.
0 Comments
Post a comment
No comments yet. Be the first to comment!